News
Explore Moderna, Inc.'s Q2 2025 earnings, with steep revenue declines and growth challenges. Click for my updated look at ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
The former Head of SAP's Center-of-Excellence will help enterprises unlock resilient, AI-ready procurement, supply-chain, and ...
Healthbeat on MSN30m
Sorting out Covid vaccine confusion: New and conflicting federal policies raise questionsIf you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...
The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...
Despite gold’s rebound, silver drops on soft China data and trade fears. Explore the full silver analysis and what it means ...
StockStory.org on MSN10h
Earnings To Watch: Myriad Genetics (MYGN) Reports Q2 Results TomorrowGenetic testing company Myriad Genetics (NASDAQ:MYGN) will be announcing earnings results this Tuesday after market hours.
This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...
An outbreak of the highly infectious livestock disease would devastate exports and wipe $80 billion from the economy.
As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.
The list of bodies that have been ousted from Advisory Committee on Immunization Practices (ACIP) workgroups includes ...
Market reacts to cooler jobs data, new tariffs & earnings highlights from Meta, Amazon, Apple, Microsoft, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results